As we approach the holiday season, it is important that our customers stay vigilant and continue a regular cadence of autonomous pentests. Although it’s the time of year for holiday cheer, we’ve seen cyber threat actors (CTAs) take advantage of lackadaisical company manning and low…
Source: news.google.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
